Roohollah Sharifi

5.2k total citations
91 papers, 2.5k citations indexed

About

Roohollah Sharifi is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Roohollah Sharifi has authored 91 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 24 papers in Surgery and 17 papers in Oncology. Recurrent topics in Roohollah Sharifi's work include Prostate Cancer Treatment and Research (27 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Hormonal and reproductive studies (14 papers). Roohollah Sharifi is often cited by papers focused on Prostate Cancer Treatment and Research (27 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Hormonal and reproductive studies (14 papers). Roohollah Sharifi collaborates with scholars based in United States, Iran and Malaysia. Roohollah Sharifi's co-authors include Phyllis E. Bowen, Mark S. Soloway, Maria Stacewicz‐Sapuntzakis, Richard B. van Breemen, Luna Ghosh, Jackson E. Fowler, Mary Lee, Russell K. Pearl, David G. McLeod and Zev Wajsman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Analytical Chemistry.

In The Last Decade

Roohollah Sharifi

89 papers receiving 2.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Roohollah Sharifi 999 437 421 382 369 91 2.5k
Luı́s Belo 287 0.3× 181 0.4× 148 0.4× 429 1.1× 490 1.3× 135 3.4k
Tetsuya Otani 677 0.7× 111 0.3× 144 0.3× 763 2.0× 611 1.7× 103 3.6k
Giovanni Montini 914 0.9× 102 0.2× 155 0.4× 631 1.7× 1.5k 4.2× 215 5.9k
Matthew Brookes 433 0.4× 460 1.1× 55 0.1× 579 1.5× 460 1.2× 121 2.9k
Sreelatha Meleth 319 0.3× 122 0.3× 100 0.2× 194 0.5× 638 1.7× 76 2.5k
R. Naccarato 528 0.5× 106 0.2× 130 0.3× 1.8k 4.8× 810 2.2× 314 6.0k
Rahul Srivastava 272 0.3× 71 0.2× 305 0.7× 410 1.1× 1.7k 4.6× 190 4.1k
Tariq Iqbal 502 0.5× 161 0.4× 68 0.2× 986 2.6× 1.2k 3.2× 176 4.9k
Joseph E. Kiss 193 0.2× 276 0.6× 124 0.3× 311 0.8× 312 0.8× 130 3.3k
Yong Yuan 819 0.8× 86 0.2× 85 0.2× 827 2.2× 800 2.2× 274 4.1k

Countries citing papers authored by Roohollah Sharifi

Since Specialization
Citations

This map shows the geographic impact of Roohollah Sharifi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roohollah Sharifi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roohollah Sharifi more than expected).

Fields of papers citing papers by Roohollah Sharifi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roohollah Sharifi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roohollah Sharifi. The network helps show where Roohollah Sharifi may publish in the future.

Co-authorship network of co-authors of Roohollah Sharifi

This figure shows the co-authorship network connecting the top 25 collaborators of Roohollah Sharifi. A scholar is included among the top collaborators of Roohollah Sharifi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roohollah Sharifi. Roohollah Sharifi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Safaei, Mohsen, Hossein Mohammadi, Salmia Beddu, et al.. (2024). Surface Topography Steer Soft Tissue Response and Antibacterial Function at the Transmucosal Region of Titanium Implant. International Journal of Nanomedicine. Volume 19. 4835–4856. 3 indexed citations
2.
3.
Myung, Ja Hye, Michael J. Poellmann, Alain Borgeat, et al.. (2019). Dendrimer-Based Platform for Effective Capture of Tumor Cells after TGFβ1-Induced Epithelial–Mesenchymal Transition. Analytical Chemistry. 91(13). 8374–8382. 10 indexed citations
4.
Fintelmann, Robert E., et al.. (2019). Precautions and Monitoring of Patients Taking Phosphodiesterase Type 5 Inhibitors Who are at Risk of Increased Intraocular Pressure. Drugs & Aging. 36(11). 991–997. 5 indexed citations
5.
Keeter, Mary Kate, Iman K. Martin, Maria Ruden, et al.. (2018). Self-reported Black race predicts significant prostate cancer independent of clinical setting and clinical and socioeconomic risk factors. Urologic Oncology Seminars and Original Investigations. 36(11). 501.e1–501.e8. 29 indexed citations
6.
Almasi, Davood, Roohollah Sharifi, Mohammed Rafiq Abdul Kadir, Krishnamurithy Genasan, & Tunku Kamarul. (2016). Study on the AFM Force Curve Common Errors and Their Effects on the Calculated Nanomechanical Properties of Materials. Journal of Engineering. 2016. 1–8. 7 indexed citations
7.
Park, Eun‐Young, Maria Stacewicz‐Sapuntzakis, Roohollah Sharifi, et al.. (2012). Diet adherence dynamics and physiological responses to a tomato product whole-food intervention in African–American men. British Journal Of Nutrition. 109(12). 2219–2230. 10 indexed citations
8.
Pickard, A. Simon, Sara J. Knight, Roohollah Sharifi, et al.. (2009). Proxy Assessment of Health-Related Quality of Life in African American and White Respondents With Prostate Cancer. Medical Care. 47(2). 176–183. 27 indexed citations
9.
Rasmi, Yousef, et al.. (2009). Frequency of ABO Blood Group in Peptic Ulcer Disease in Iranian Subjects. Pakistan Journal of Biological Sciences. 12(13). 991–993. 13 indexed citations
10.
Pickard, A. Simon, June M. McKoy, Whitney P. Witt, et al.. (2005). Opportunities for Disease State Management in Prostate Cancer. Disease Management. 8(4). 235–244. 5 indexed citations
11.
Siston, Amy, Sara J. Knight, Nicholas P. Slimack, et al.. (2003). Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study. Urology. 61(1). 172–178. 27 indexed citations
12.
Knight, Sara J., Joan S. Chmiel, Lisa K. Sharp, et al.. (2001). Spouse ratings of quality of life in patients with metastatic prostate cancer of lower socioeconomic status: an assessment of feasibility, reliability, and validity. Urology. 57(2). 275–280. 19 indexed citations
13.
Fowler, Jackson E., et al.. (2000). Evaluation of an implant that delivers leuprolide for 1 year for the palliative treatment of prostate cancer. Urology. 55(5). 639–642. 39 indexed citations
14.
Sharp, Lisa K., Sara J. Knight, Robert B. Nadler, et al.. (1999). Quality of life in low-income patients with metastatic prostate cancer: Divergent and convergent validity of three instruments. Quality of Life Research. 8(5). 461–470. 26 indexed citations
15.
Sharifi, Roohollah, et al.. (1998). Leuprolide acetate (30-mg depot every four months) in the treatment of advanced prostate cancer. Urology. 51(2). 271–276. 49 indexed citations
16.
17.
18.
Sharifi, Roohollah, Reginald C. Bruskewitz, Marc Gittleman, et al.. (1996). Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer. Clinical Therapeutics. 18(4). 647–657. 66 indexed citations
19.
Sharifi, Roohollah, Migyung Lee, Damon G. Lamb, et al.. (1991). Phase I-II evaluation of intravesical novantrone (mitoxantrone) in superficial bladder cancer. Anti-Cancer Drugs. 2(2). 153–158. 5 indexed citations
20.
Chakrabarty, Krishna, Jayant Radhakrishnan, Roohollah Sharifi, et al.. (1988). Lipogenic activity and brown fat content of human perirenal adipose tissue. Clinical Biochemistry. 21(4). 249–254. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luı́s Belo Breakdown of academic impact, for papers by Tetsuya Otani Breakdown of academic impact, for papers by Giovanni Montini Breakdown of academic impact, for papers by Matthew Brookes Breakdown of academic impact, for papers by Sreelatha Meleth Breakdown of academic impact, for papers by R. Naccarato Breakdown of academic impact, for papers by Rahul Srivastava Breakdown of academic impact, for papers by Tariq Iqbal Breakdown of academic impact, for papers by Joseph E. Kiss Breakdown of academic impact, for papers by Yong Yuan
Rankless by CCL
2026